An announcement from EKF Diagnostics Holdings ( (GB:EKF) ) is now available.
EKF Diagnostics Holdings plc has appointed Gavin Jones as the new Chief Executive Officer. Gavin, who previously served as Chief Product Officer, brings extensive experience in analytical chemistry and diagnostics, having contributed significantly to product innovation and operational excellence. His appointment is expected to drive sustainable growth and unlock the potential of EKF’s core products and services, with a focus on expanding point-of-care solutions and strengthening market presence in life sciences.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business that focuses on point-of-care analyzers in hematology and diabetes, as well as life sciences services that provide specialist manufacturing of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling to over 120 countries worldwide.
YTD Price Performance: -24.07%
Average Trading Volume: 399,122
Technical Sentiment Signal: Buy
Current Market Cap: £93.01M
For detailed information about EKF stock, go to TipRanks’ Stock Analysis page.